| Historic (2004-11-01 to
2009-09-02) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Zoloft
|
7739 |
85902.7 |
  |
| 2 |
Prozac
|
7090 |
73986.1 |
  |
| 3 |
Celexa
|
2596 |
30423.9 |
  |
| 4 |
SSRI
|
2532 |
29743.9 |
  |
| 5 |
Luvox
|
1746 |
21699.7 |
  |
| 6 |
GlaxoSmithKline
|
1859 |
21362.7 |
  |
| 7 |
FDA
|
2016 |
20665.5 |
  |
| 8 |
Effexor
|
1378 |
17906.2 |
  |
| 9 |
depression
|
1553 |
15575.0 |
  |
| 10 |
Lexapro
|
1173 |
15025.4 |
  |
| 11 |
CR
|
1078 |
14417.5 |
  |
| 12 |
birth defects
|
1170 |
13588.4 |
  |
| 13 |
heart defects
|
869 |
10898.6 |
  |
| 14 |
selective serotonin reuptake inhibitors
|
903 |
10717.6 |
  |
| 15 |
SSRIs
|
832 |
9938.2 |
  |
|
| 365 days (2008-09-02 to
2009-09-02) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Zoloft
|
1718 |
19724.4 |
  |
| 2 |
Prozac
|
1216 |
12562.7 |
  |
| 3 |
SSRI
|
1004 |
11584.6 |
  |
| 4 |
Luvox
|
700 |
8378.3 |
  |
| 5 |
Celexa
|
617 |
7121.2 |
  |
| 6 |
Lexapro
|
220 |
2780.8 |
  |
| 7 |
Breast cancer
|
176 |
2226.2 |
  |
| 8 |
Wellbutrin
|
110 |
1684.6 |
  |
| 9 |
Xanax
|
120 |
1673.7 |
  |
| 10 |
Effexor
|
102 |
1435.9 |
  |
| 11 |
Cymbalta
|
83 |
1235.1 |
  |
| 12 |
depression
|
102 |
1232.9 |
  |
| 13 |
birth defects
|
101 |
1208.1 |
  |
| 14 |
zoloft
|
66 |
887.0 |
  |
| 15 |
Valium
|
59 |
858.1 |
  |
|
| 30 days (2009-08-03 to
2009-09-02) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Zoloft
|
70 |
1080.7 |
  |
| 2 |
Associated Press
|
30 |
412.9 |
  |
| 3 |
GlaxoSmithKline
|
20 |
336.2 |
  |
| 4 |
Luvox
|
20 |
323.6 |
  |
| 5 |
SSRI
|
20 |
304.0 |
  |
| 6 |
Marty Mumun Barbaros
|
20 |
259.8 |
  |
| 7 |
GlaxoSmithKline PLC
|
10 |
177.9 |
  |
| 8 |
Drugmaker GlaxoSmithKline
|
10 |
172.8 |
  |
| 9 |
WASHINGTON Drugmaker GlaxoSmithKline
|
10 |
172.8 |
  |
| 10 |
Delli Sante
|
10 |
167.5 |
  |
| 11 |
Celexa
|
10 |
165.9 |
  |
| 12 |
CASPPER
|
10 |
160.0 |
  |
| 13 |
4 days
|
10 |
157.1 |
  |
| 14 |
Prozac
|
10 |
153.3 |
  |
| 15 |
depression
|
10 |
153.3 |
  |
|